286 related articles for article (PubMed ID: 10499735)
1. Prednisone and vinblastine chemotherapy for canine mast cell tumor--41 cases (1992-1997).
Thamm DH; Mauldin EA; Vail DM
J Vet Intern Med; 1999; 13(5):491-7. PubMed ID: 10499735
[TBL] [Abstract][Full Text] [Related]
2. Outcome and prognostic factors following adjuvant prednisone/vinblastine chemotherapy for high-risk canine mast cell tumour: 61 cases.
Thamm DH; Turek MM; Vail DM
J Vet Med Sci; 2006 Jun; 68(6):581-7. PubMed ID: 16820715
[TBL] [Abstract][Full Text] [Related]
3. Aggressive local therapy combined with systemic chemotherapy provides long-term control in grade II stage 2 canine mast cell tumour: 21 cases (1999-2012).
Lejeune A; Skorupski K; Frazier S; Vanhaezebrouck I; Rebhun RB; Reilly CM; Rodriguez CO
Vet Comp Oncol; 2015 Sep; 13(3):267-80. PubMed ID: 23721492
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of neoadjuvant prednisone administration and surgical excision in treatment of cutaneous mast cell tumors in dogs.
Stanclift RM; Gilson SD
J Am Vet Med Assoc; 2008 Jan; 232(1):53-62. PubMed ID: 18167109
[TBL] [Abstract][Full Text] [Related]
5. A phase II study to evaluate the toxicity and efficacy of alternating CCNU and high-dose vinblastine and prednisone (CVP) for treatment of dogs with high-grade, metastatic or nonresectable mast cell tumours.
Rassnick KM; Bailey DB; Russell DS; Flory AB; Kiselow MA; Intile JL; Malone EK; Balkman CE; Barnard SM
Vet Comp Oncol; 2010 Jun; 8(2):138-52. PubMed ID: 20579327
[TBL] [Abstract][Full Text] [Related]
6. Dose-escalating vinblastine for the treatment of canine mast cell tumour.
Vickery KR; Wilson H; Vail DM; Thamm DH
Vet Comp Oncol; 2008 Jun; 6(2):111-9. PubMed ID: 19178670
[TBL] [Abstract][Full Text] [Related]
7. Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumours: 21 cases.
Taylor F; Gear R; Hoather T; Dobson J
J Small Anim Pract; 2009 Jun; 50(6):284-9. PubMed ID: 19527421
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant CCNU (lomustine) and prednisone chemotherapy for dogs with incompletely excised grade 2 mast cell tumors.
Hosoya K; Kisseberth WC; Alvarez FJ; Lara-Garcia A; Beamer G; Stromberg PC; Couto CG
J Am Anim Hosp Assoc; 2009; 45(1):14-8. PubMed ID: 19122059
[TBL] [Abstract][Full Text] [Related]
9. Response of canine mast cell tumors to treatment with oral prednisone.
McCaw DL; Miller MA; Ogilvie GK; Withrow SJ; Brewer WG; Klein MK; Bell FW; Anderson SK
J Vet Intern Med; 1994; 8(6):406-8. PubMed ID: 7884726
[TBL] [Abstract][Full Text] [Related]
10. A phase II clinical trial of vinorelbine in dogs with cutaneous mast cell tumors.
Grant IA; Rodriguez CO; Kent MS; Sfilgoi G; Gordon I; Davis G; Lord L; London CA
J Vet Intern Med; 2008; 22(2):388-93. PubMed ID: 18312556
[TBL] [Abstract][Full Text] [Related]
11. Adverse haematological effects of vinblastine, prednisolone and cimetidine treatment: a retrospective study in fourteen dogs with mast cell tumours.
Trumel C; Bourgès-Abella N; Touron C; Lanore D; Geffré A; Diquelou A; Guelfi JF; Braun JP
J Vet Med A Physiol Pathol Clin Med; 2005 Aug; 52(6):275-9. PubMed ID: 16050908
[TBL] [Abstract][Full Text] [Related]
12. Vinblastine and prednisolone as adjunctive therapy for canine cutaneous mast cell tumors.
Davies DR; Wyatt KM; Jardine JE; Robertson ID; Irwin PJ
J Am Anim Hosp Assoc; 2004; 40(2):124-30. PubMed ID: 15007048
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004).
Mullins MN; Dernell WS; Withrow SJ; Ehrhart EJ; Thamm DH; Lana SE
J Am Vet Med Assoc; 2006 Jan; 228(1):91-5. PubMed ID: 16426175
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of prognostic markers for canine mast cell tumors treated with vinblastine and prednisone.
Webster JD; Yuzbasiyan-Gurkan V; Thamm DH; Hamilton E; Kiupel M
BMC Vet Res; 2008 Aug; 4():32. PubMed ID: 18700956
[TBL] [Abstract][Full Text] [Related]
15. c-Kit Mutation and Localization Status as Response Predictors in Mast Cell Tumors in Dogs Treated with Prednisone and Toceranib or Vinblastine.
Weishaar KM; Ehrhart EJ; Avery AC; Charles JB; Elmslie RE; Vail DM; London CA; Clifford CA; Eickhoff JC; Thamm DH
J Vet Intern Med; 2018 Jan; 32(1):394-405. PubMed ID: 29194765
[TBL] [Abstract][Full Text] [Related]
16. Biologic behavior and prognostic factors for mast cell tumors of the canine muzzle: 24 cases (1990-2001).
Gieger TL; Théon AP; Werner JA; McEntee MC; Rassnick KM; DeCock HE
J Vet Intern Med; 2003; 17(5):687-92. PubMed ID: 14529136
[TBL] [Abstract][Full Text] [Related]
17. Hypotonic water as adjuvant therapy for incompletely resected canine mast cell tumors: a randomized, double-blind, placebo-controlled study.
Brocks BA; Neyens IJ; Teske E; Kirpensteijn J
Vet Surg; 2008 Jul; 37(5):472-8. PubMed ID: 18986315
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylated KIT as a predictor of outcome in canine mast cell tumours treated with toceranib phosphate or vinblastine.
Thamm DH; Weishaar KM; Charles JB; Ehrhart EJ
Vet Comp Oncol; 2020 Jun; 18(2):169-175. PubMed ID: 31365175
[TBL] [Abstract][Full Text] [Related]
19. Multicenter prospective trial of hypofractionated radiation treatment, toceranib, and prednisone for measurable canine mast cell tumors.
Carlsten KS; London CA; Haney S; Burnett R; Avery AC; Thamm DH
J Vet Intern Med; 2012; 26(1):135-41. PubMed ID: 22176473
[TBL] [Abstract][Full Text] [Related]
20. Results of radiation therapy in 19 dogs with cutaneous mast cell tumor and regional lymph node metastasis.
Chaffin K; Thrall DE
Vet Radiol Ultrasound; 2002; 43(4):392-5. PubMed ID: 12175005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]